UBS Group’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

UBS Group’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,855	Closed	-$139K	–	8947
2015 Q3	$139K	Sell	1,855 -3,293	-64%	-$246K	﹤0.01%	4948
2015 Q2	$388K	Sell	5,148 -6,000	-54%	-$321K	﹤0.01%	4327
2015 Q1	$559K	Sell	11,148 -27,605	-71%	-$1.16M	﹤0.01%	4051
2014 Q4	$1.34M	Buy	+38,753	New	+$1.35M	﹤0.01%	3320

UBS Group's KYTH Position: Q4 2015 in Review

UBS Group sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 1,855 shares — an estimated $139K sold.

UBS Group first reported a position in KYTH in Q4 2014 and held it in 4 quarters. The position peaked at $1.34M in Q4 2014. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

UBS Group reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
UBS Group sold 1,855 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $139K.
UBS Group first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2014 and held it in 4 quarters.
UBS Group's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $1.34M in Q4 2014.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on UBS Group's 13F filing for Q4 2015, filed 16 Feb 2016.